We are live on ! Find out more
U

UBS Portfolio holdings

AUM $136B
1-Year Est. Return 16.36%
This Fund
S&P 500
This Quarter Est. Return
+5.64%
1 Year Est. Return
+16.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$97.7B
AUM Growth
+$13.4B
Cap. Flow
+$8.11B
Cap. Flow %
8.3%
Top 10 Hldgs %
14.79%
Holding
11,408
New
1,114
Increased
4,572
Reduced
4,158
Closed
1,006

Sector Composition

Rank Sector Weight
1 Energy 9.1%
2 Healthcare 6.42%
3 Technology 5.93%
4 Financials 5.8%
5 Industrials 5.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BYI
6026
DELISTED
BALLY TECHNOLOGIES, INC.
BYI
$98K ﹤0.01%
1,348
-25,564
-95% -$1.8M
MTL
6027
CALL
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
$98K ﹤0.01%
15,250
-100
-0.7% -$625
IMUC
6028
PUT
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
$98K ﹤0.01%
955
+845
+768% +$92.8K
FTK icon
6029
CALL
Flotek Industries
FTK
$964M
$97K ﹤0.01%
700
+600
+600% +$72.8K
FXC icon
6030
CALL
Invesco CurrencyShares Canadian Dollar Trust
FXC
$69.4M
$97K ﹤0.01%
1,000
-1,900
-66% -$182K
HRL icon
6031
CALL
Hormel Foods
HRL
$13.8B
$97K ﹤0.01%
4,600
+2,600
+130% +$54.6K
LFVN icon
6032
LifeVantage
LFVN
$82.5M
$97K ﹤0.01%
5,839
+5,696
+3,983% +$98.4K
ADAM
6033
Adamas Trust
ADAM
$844M
$97K ﹤0.01%
3,898
-2,756
-41% -$69.4K
SDY icon
6034
PUT
State Street SPDR S&P Dividend ETF
SDY
$23.5B
$97K ﹤0.01%
1,400
+400
+40% +$27.6K
VONE icon
6035
Vanguard Russell 1000 ETF
VONE
$8.48B
$97K ﹤0.01%
1,245
+470
+61% +$36.3K
NTUS
6036
DELISTED
Natus Medical Inc
NTUS
$97K ﹤0.01%
6,879
-2,671
-28% -$35.7K
OTIV
6037
DELISTED
OTI On Track Innovations Ltd
OTIV
$97K ﹤0.01%
61,003
+9,010
+17% +$14.8K
WAGE
6038
DELISTED
WageWorks, Inc.
WAGE
$97K ﹤0.01%
1,920
+1,853
+2,766% +$76.4K
MACK
6039
CALL
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$97K ﹤0.01%
+3,254
New +$114K
NUJ
6040
DELISTED
NUVEEN NEW JERSEY DIV ADVTG MUNI FD 2
NUJ
$97K ﹤0.01%
7,793
+1,135
+17% +$14K
EXXI
6041
PUT
DELISTED
ENERGY XXI LTD COM SHS
EXXI
$97K ﹤0.01%
3,200
+2,000
+167% +$53.7K
PXLC
6042
DELISTED
POWERSHARES FUNDAMENTAL PURE LARGE CORE PORTFOLIO
PXLC
$97K ﹤0.01%
2,947
-802
-21% -$26.6K
ARE icon
6043
PUT
Alexandria Real Estate Equities
ARE
$8.7B
$96K ﹤0.01%
1,500
CLMT icon
6044
CALL
Calumet Specialty Products
CLMT
$3.68B
$96K ﹤0.01%
3,500
-3,500
-50% -$110K
CVI icon
6045
PUT
CVR Energy
CVI
$3.26B
$96K ﹤0.01%
2,500
-200
-7% -$8.77K
EWT icon
6046
CALL
iShares MSCI Taiwan ETF
EWT
$10.5B
$96K ﹤0.01%
3,450
-1,300
-27% -$35.6K
ICLN icon
6047
iShares Global Clean Energy ETF
ICLN
$2.39B
$96K ﹤0.01%
9,400
-1,200
-11% -$11.2K
MVO
6048
DELISTED
MV Oil Trust
MVO
$96K ﹤0.01%
3,284
+794
+32% +$22.5K
PEGA icon
6049
Pegasystems
PEGA
$5.17B
$96K ﹤0.01%
9,708
+5,720
+143% +$52.3K
RTEC
6050
DELISTED
Rudolph Technologies Inc
RTEC
$96K ﹤0.01%
8,360
+5,936
+245% +$68K

Similar funds

UBS's Q3 2013 Portfolio in Review

As of Q3 2013, UBS held 11,408 positions worth $97.7B, up 16% from $84.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

UBS deployed $8.11B of net new capital in Q3 2013, opening 1,114 new positions and adding to 4,572 existing holdings. Its largest new stake was COLE REAL ESTATE INVESTMENTS, INC COM: 11,625,569 shares worth $143M.

By sector, the portfolio is most concentrated in Energy at 9.1% of assets, down from 9.5% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Nuance Communications, Inc., an estimated $308M trimmed.

  • UBS's largest Q3 2013 buy was COLE REAL ESTATE INVESTMENTS, INC COM: 11,625,569 shares worth $143M.
  • UBS added most to Mastercard in Q3 2013, an estimated $185M increase.
  • UBS's biggest Q3 2013 reduction was Nuance Communications, Inc., cutting an estimated $308M.
  • UBS fully exited THE NEWS CORPORATION LTD CL-B in Q3 2013, selling an estimated $30.8M.
  • UBS's ten largest holdings make up 15% of its $97.7B portfolio in Q3 2013.
  • UBS opened 1,114 new positions and closed 1,006 in Q3 2013.
  • UBS's portfolio value rose 16% quarter-over-quarter to $97.7B.

Based on UBS's 13F filing for Q3 2013, filed 13 Nov 2013.